	BIEO	IOB2
Oral	O	O
cancer	O	O
eleventh	O	O
common	O	O
cancer	O	O
globally	O	O
,	O	O
well-established	O	O
major	O	O
risk	O	O
factors	O	O
tobacco	O	O
,	O	O
areca	O	O
nut	O	O
,	O	O
alcohol	O	O
,	O	O
high-risk	B-virus	B-virus
human	I-virus	I-virus
papillomavirus	E-virus	I-virus
(	O	O
HR-HPV	B-virus	B-virus
)	O	O
types	O	O
16	O	O
18	O	O
.	O	O
		
HR-HPV16/18	B-virus	B-virus
etiologic	O	O
agents	O	O
cervical	O	O
cancers	O	O
proportion	O	O
oropharyngeal	O	O
cancers	O	O
.	O	O
		
HPV-associated	B-virus	B-virus
oropharyngeal	O	O
oral	O	O
cancers	O	O
show	O	O
better	O	O
prognosis	O	O
response	O	O
therapy	O	O
.	O	O
		
However	O	O
,	O	O
picture	O	O
HR-HPV16/18	B-virus	B-virus
clinical	O	O
implications	O	O
oral	O	O
cancers	O	O
clear	O	O
majority	O	O
reports	O	O
combining	O	O
oral	O	O
cancer	O	O
data	O	O
head	O	O
neck	O	O
cancers	O	O
.	O	
		
The	O	O
current	O	O
review	O	O
compiles	O	O
global	O	O
prevalence	O	O
HR-HPV16/18	B-virus	B-virus
oral	O	O
cancers	O	O
,	O	O
highlighting	O	O
unique	O	O
clinical	O	O
molecular	O	O
pathologic	O	O
features	O	O
,	O	O
prognosis	O	O
therapeutic	O	O
strategies	O	O
prevention	O	O
management	O	O
HPV-positive	B-virus	B-virus
oral	O	O
cancers	O	O
.	O	O
		
The	O	O
potential	O	O
use	O	O
de-intensified	O	O
therapy	O	O
prophylactic	O	O
prevention	O	O
HPV-positive	B-virus	B-virus
oral	O	O
cancer	O	O
patients	O	O
highlighted	O	O
.	O	O
